These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 862343)

  • 1. The effect of 25-hydroxy vitamin D3 in the osteomalacia of chronic renal failure.
    Eastwood JB; Stamp TC; De Wardener HE; Bordier PJ; Arnaud CD
    Clin Sci Mol Med; 1977 May; 52(5):499-508. PubMed ID: 862343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin-D deficiency in the osteomalacia of chronic renal failure.
    Eastwood JB; Stamp TC; Harris E; de Wardener HE
    Lancet; 1976 Dec; 2(7997):1209-11. PubMed ID: 63038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of uremic osteoid to vitamin D.
    Memmos DE; Eastwood JB; Harris E; O'Grady A; de Wardener HE
    Kidney Int Suppl; 1982 May; 11():S50-4. PubMed ID: 6956774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D metabolites and bone mineralization in man.
    Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
    J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of vitamin D metabolites on mineralization of bone tissue and phosphocalcium metabolism disorders in the course of vitamin D deficiency osteomalacia].
    Bordier P; Miravet L; Marie P; Guéris J; Rousselet F; Norman A; Rasmussen H; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1978 Apr; 45(4):241-8. PubMed ID: 353964
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical and histological effects of 1,25 dihydroxycholecalciferol (1,25-DHCC) in the osteomalacia of chronic and failure.
    Eastwood JB; Phillips ME; de Wardener HE; Bordier J; Marie P; Arnaud CD; Norman AW
    J Urol Nephrol (Paris); 1974 Dec; 80(12):984-5. PubMed ID: 4617780
    [No Abstract]   [Full Text] [Related]  

  • 7. 25-hydroxyvitamin-D deficiency and osteomalacia of chronic renal failure.
    Brancaccio D; Graziani G; Galmozzi C; Ponticelli C
    Lancet; 1977 Jan; 1(8004):199. PubMed ID: 64734
    [No Abstract]   [Full Text] [Related]  

  • 8. Response of adult patients with osteomalacia to treatment with crystalline 1alpha-hydroxy vitamin D3.
    Bordier P; Pechet MM; Hesse R; Marie P; Rasmussen H
    N Engl J Med; 1974 Oct; 291(17):866-71. PubMed ID: 4415589
    [No Abstract]   [Full Text] [Related]  

  • 9. Vitamin D resistant hypophosphataemic osteomalacia: treatment with 1alpha-hydroxyvitamin D3.
    Peacock M; Heyburn PJ; Aaron JE
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():231s-237s. PubMed ID: 203418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of vitamin D resistant hypophosphataemic osteomalacia with 1alpha-hydroxy vitamin D3.
    Peacock M; Heyburn PJ; Aaron JE
    Calcif Tissue Res; 1977 May; 22 Suppl():55-62. PubMed ID: 912585
    [No Abstract]   [Full Text] [Related]  

  • 11. Parenteral 1,25-dihydroxycholecalciferol in hepatic osteomalacia.
    Long RG; Varghese Z; Meinhard EA; Skinner RK; Wills MR; Sherlock S
    Br Med J; 1978 Jan; 1(6105):75-7. PubMed ID: 620204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term therapy with calcitriol in patients with moderate renal failure.
    Healy MD; Malluche HH; Goldstein DA; Singer FR; Massry SG
    Arch Intern Med; 1980 Aug; 140(8):1030-3. PubMed ID: 6893118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of osteomalacia associated with primary biliary cirrhosis with oral 1-alpha-hydroxy vitamin D3.
    Compston JE; Crowe JP; Horton LW
    Br Med J; 1979 Aug; 2(6185):309. PubMed ID: 476441
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolites of vitamin D in human vitamin-D deficiency: effect of vitamin D3 or 1,25-dihydroxycholecalciferol.
    Papapoulos SE; Clemens TL; Fraher LJ; Gleed J; O'Riordan JL
    Lancet; 1980 Sep; 2(8195 pt 1):612-5. PubMed ID: 6107407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 25-hydroxycholecalciferol on bone lesions of children with terminal renal failure.
    Witmer G; Margolis A; Fontaine O; Fritsch J; Lenoir G; Broyer M; Balsan S
    Kidney Int; 1976 Nov; 10(5):395-408. PubMed ID: 794558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contrasting effects on bone histology of vitamin D and of calcium carbonate in the osteomalacia of chronic renal failure.
    Eastwood JB; Bordier PJ; Clarkson EM; Tun Chot S; de Wardener HE
    Clin Sci Mol Med; 1974 Jul; 47(1):23-42. PubMed ID: 4854694
    [No Abstract]   [Full Text] [Related]  

  • 17. Bone disease and hyperparathyroidism in chronic renal failure: the effect of 1alpha-hydroxyvitamin D3.
    Peacock M; Aaron JE; Walker GS; Davison AM
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():73s-81s. PubMed ID: 606428
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of osteomalacia associated with primary biliary cirrhosis with parenteral vitamin D2 or oral 25-hydroxyvitamin D3.
    Compston JE; Horton LW; Thompson RP
    Gut; 1979 Feb; 20(2):133-6. PubMed ID: 311747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1alpha-hydroxyvitamin D3 in the treatment of nutritional and metabolic rickets and osteomalacia.
    Gertner JM; Brenton DB; Edwards RH
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():239s-244s. PubMed ID: 203419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term effects of vitamin D3 and 1,25-dihydroxyvitamin D3 on osteomalacia in uremic rats fed a low calcium-low-phosphorus diet.
    Weisbrode SE
    Am J Pathol; 1981 Jul; 104(1):35-40. PubMed ID: 6266257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.